Literature DB >> 24759152

Discovery of an integrative network of microRNAs and transcriptomics changes for acute kidney injury.

Chan Gyu Lee1, Jin Geol Kim1, Hyun Joo Kim1, Hyuk-Kwon Kwon2, Il Je Cho3, Dal Woong Choi4, Woo Hyung Lee1, Won Dong Kim1, Se Jin Hwang5, Sangdun Choi2, Sang Geon Kim1.   

Abstract

The contribution of miRNA to the pathogenesis of acute kidney injury (AKI) is not well understood. Here we evaluated an integrative network of miRNAs and mRNA data to discover a possible master regulator of AKI. Microarray analyses of the kidneys of mice treated with cisplatin were used to extract putative miRNAs that cause renal injury. Of them, miR-122 was mostly downregulated by cisplatin, whereas miR-34a was upregulated. A network integrating dysregulated miRNAs and altered mRNA expression along with target prediction enabled us to identify Foxo3 as a core protein to activate p53. The miR-122 inhibited Foxo3 translation as assessed using an miR mimic, an inhibitor, and a Foxo3 3'-UTR reporter. In a mouse model, Foxo3 levels paralleled the degree of tubular injury. The role of decreased miR-122 in inducing Foxo3 during AKI was strengthened by the ability of the miR-122 mimic or inhibitor to replicate results. Increase in miR-34a also promoted the acetylation of Foxo3 by repressing Sirt1. Consistently, cisplatin facilitated the binding of Foxo3 and p53 for activation, which depended not only on decreased miR-122 but also on increased miR-34a. Other nephrotoxicants had similar effects. Among targets of p53, Phlda3 was robustly induced by cisplatin, causing tubular injury. Consistently, treatment with miR mimics and/or inhibitors, or with Foxo3 and Phlda3 siRNAs, modulated apoptosis. Thus, our results uncovered an miR integrative network regulating toxicant-induced AKI and identified Foxo3 as a bridge molecule to the p53 pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24759152     DOI: 10.1038/ki.2014.117

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  38 in total

Review 1.  Does Renal Repair Recapitulate Kidney Development?

Authors:  Melissa Helen Little; Pamela Kairath
Journal:  J Am Soc Nephrol       Date:  2016-10-26       Impact factor: 10.121

Review 2.  Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies.

Authors:  Alieh Gholaminejad; Hossein Abdul Tehrani; Mohammad Gholami Fesharaki
Journal:  J Nephrol       Date:  2018-07-17       Impact factor: 3.902

Review 3.  Renal extracellular vesicles: from physiology to clinical application.

Authors:  E E Morrison; M A Bailey; J W Dear
Journal:  J Physiol       Date:  2016-05-27       Impact factor: 5.182

Review 4.  Proximal Tubular Transcription Factors in Acute Kidney Injury: Recent Advances.

Authors:  Sian E Piret; Sandeep K Mallipattu
Journal:  Nephron       Date:  2020-07-09       Impact factor: 2.847

5.  MicroRNAs in Pathogenesis of Acute Kidney Injury.

Authors:  Zhiwen Liu; Shixuan Wang; Qing-Sheng Mi; Zheng Dong
Journal:  Nephron       Date:  2016-06-21       Impact factor: 2.847

Review 6.  Epigenetics: a potential key mechanism involved in the pathogenesis of cardiorenal syndromes.

Authors:  Grazia Maria Virzì; Anna Clementi; Alessandra Brocca; Massimo de Cal; Claudio Ronco
Journal:  J Nephrol       Date:  2017-08-05       Impact factor: 3.902

Review 7.  Role of microRNA in the detection, progression, and intervention of acute kidney injury.

Authors:  Yan-Fang Zou; Wen Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2017-12-21

Review 8.  MicroRNAs and drug-induced kidney injury.

Authors:  Mira Pavkovic; Vishal S Vaidya
Journal:  Pharmacol Ther       Date:  2016-04-25       Impact factor: 12.310

Review 9.  Inflammation in AKI: Current Understanding, Key Questions, and Knowledge Gaps.

Authors:  Hamid Rabb; Matthew D Griffin; Dianne B McKay; Sundararaman Swaminathan; Peter Pickkers; Mitchell H Rosner; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2015-11-11       Impact factor: 10.121

10.  Apoptosis and autophagy in polycystic kidney disease (PKD).

Authors:  Kristen L Nowak; Charles L Edelstein
Journal:  Cell Signal       Date:  2019-12-24       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.